Log In
Or login using:
Sign Up
Or sign up using:
Forgotten Password
Upgrade to a paid membership and never see an advert again!
Why do we display adverts? The advertisements supplied by our carefully selected sponsors enable us to host and support the company data we share with our free members.
Watch this company for free updates
Simply enter your email address below and we will send you an email when the company files any documents or there is a change to their credit report.
We require your email address in order to send you alerts by email. You can unsubscribe at any time.
Thank you, you are now watching this company.
You will receive email updates when this company's information changes.
You can choose which alerts you receive and can unsubscribe at any time.
Unlock CELL THERAPY CATAPULT LIMITED's Credit Report?
Buy This Report
- 12 months access to this report
- Free email alerts for key changes
- Includes 5 Companies House documents
- Personal dashboard to track and monitor companies at a glance
- Company scores, financials, risk indicators, CCJ's & payment data
- Directors, shareholders & ownership details
Upgrade to Lite
- 5 credit reports
- 100 accounts downloads
- 100 accounts exports
Your plan will start immediately and the time remaining on your existing plan will be refunded
Yes, upgrade to LiteCELL THERAPY CATAPULT LIMITED
12th,
Floor Tower Wing B Guys Hospital,
London,
Southwark,
SE1 9RT
Download PDF
Unlock the Full Company Report
- ✓ Check whether this company is legitimate
- ✓ See if this company is likely to run into financial trouble
- ✓ Find out who owns and runs the company
- ✓ Avoid risky business relationships
- ✓ Get instant updates if anything important changes
- ✓ Access official company documents for free
CELL THERAPY CATAPULT LIMITED
Private Ltd By Guarantee w/o Share Cap
Active - Accounts Filed
24 February 2012
74909 Other professional, scientific and technical activities n.e.c. - Other professional, scientific and technical activities n.e.c.
Available to 03 Dec 2025. Next accounts due by 31 Dec 2026
Is CELL THERAPY CATAPULT LIMITED in debt to you?
Don't write it off. As exclusively featured on Can't Pay? We'll Take It Away!, DCBL provides a nationwide service recovering over £85 million annually.
Our unique "One Solution" works seamlessly with DCB Legal, managing debt recovery from the first letter through to High Court enforcement.
We act fast to protect your cash flow and recover what you're owed. Recover your debt with the UK's experts.
Current Directors & Secretaries
For a full in-depth analysis on each of these directors, click any of the links below
| Name | Role | Date Of Birth | Appointed |
|---|---|---|---|
| Dr Hsin Loke | Director | ||
| Dr Nicole Mather | Director | ||
| Dr Carolyn Porter | Director | ||
| Mr Jim Faulkner | Director | ||
| Prof Angela Eleine Thomas | Director | ||
| Professor Sir Bruce Edward Keogh | Director | ||
| Professor Uta Griesenbach | Director | ||
| Ms Hilary Jane Newiss | Director | ||
| Ms Jacqueline Anne Barry | Director | ||
| Mr Matthew Brian Durdy | Director | ||
| Dr Steven Neville Chatfield | Director | ||
| Dr Stephen Ward | Director |
Previous Directors & Secretaries
Mortgages and Charges
Total Outstanding
2
Total Satisfied
0
| Type | Created | Registered | Persons Entitled | Status |
|---|---|---|---|---|
| Innovate Uk, Part Of Uk Research And Innovation | OUTSTANDING | |||
| Technology Strategy Board | OUTSTANDING |
Key Financials
| Accounts | |||||
|---|---|---|---|---|---|
| Cash | £37,809,000.00 | £35,755,000.00 | £34,204,000.00 | £33,702,000.00 | £29,071,000.00 |
| Net Worth | £68,026,000.00 | £74,044,000.00 | £79,534,000.00 | £76,420,000.00 | £69,517,000.00 |
| Total Current Liabilities | £31,303,000.00 | £23,076,000.00 | £30,607,000.00 | £26,036,000.00 | £18,774,000.00 |
| Total Current Assets | £54,118,000.00 | £60,619,000.00 | £61,008,000.00 | £60,461,000.00 | £47,091,000.00 |
Frequently Asked Questions about CELL THERAPY CATAPULT LIMITED
Detailed answers about CELL THERAPY CATAPULT LIMITED, including incorporation, status, business activity, and accounts information.
When was CELL THERAPY CATAPULT LIMITED founded?
CELL THERAPY CATAPULT LIMITED was officially incorporated on 24 February 2012 and is registered under company number 07964711. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is CELL THERAPY CATAPULT LIMITED?
Private Ltd By Guarantee w/o Share Cap. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. For example, a private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of CELL THERAPY CATAPULT LIMITED?
CELL THERAPY CATAPULT LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does CELL THERAPY CATAPULT LIMITED do?
CELL THERAPY CATAPULT LIMITED operates in the following sector: 74909 Other professional, scientific and technical activities n.e.c. - Other professional, scientific and technical activities n.e.c. . This provides insight into the company’s primary business activities and industry focus. Knowing the SIC code and description is useful for market research, assessing competitors, and understanding potential business risks.
What is CELL THERAPY CATAPULT LIMITED's registered address?
The registered office address of CELL THERAPY CATAPULT LIMITED is 12th, Floor Tower Wing B Guys Hospital, London, Southwark, SE1 9RT. This is the official address filed with Companies House for legal and statutory correspondence.
Is CELL THERAPY CATAPULT LIMITED financially stable?
Based on the latest accounts up to 03 Dec 2025, CELL THERAPY CATAPULT LIMITED has filed financial statements showing its assets, liabilities, and overall trading performance. The next accounts are due by 31 Dec 2026. Reviewing these accounts helps assess the company’s financial stability, creditworthiness, and risk profile, which is crucial for investors, suppliers, and potential business partners.